Human Clinical Trial for the Efficacy of [IDENEL PEPTACELL and GLUTAGEN Product Treatment] in Improving facial wrinkles, lifting, skin density, pigmentation, skin texture, and pores

Human clinical Trial for the efficacy of [IDENEL PEPTAXEL INTENSIVE SOLUTION POWDER + IDENEL PEPTAXEL REGEN CONCENTRATE + IDENEL GLUTAGEN SKIN BOOSTER M + HANDHELD CRYOCELL] in improving facial wrinkles (eye area, nasolabial folds), skin density, melasma and pigmentation, skin texture, pores, and providing a facial lifting effect before 2 procedures, before 4 procedures and 4 weeks after 5 procedures

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0011125

Enrollment

Registered

2025-11-10

Start date

2024-10-21

Completion date

Unknown

Last updated

2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Others(Use cosmetics and beauty devices) : One side was designated as a test group which the 3 types of cosmetics and 1 type of beauty device (IDENEL PEPTAXEL INTENSIVE SOLUTION POWDER + IDENEL PEPTAX

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: - Healthy Korean female adult over the age of 30 - Subjects who have wrinkles around the eyes and nasolabial folds - Subjects who have signed consent form voluntarily after being informed sufficiently on the objectives of study and all related contents - Subjects who are healthy without acute and chronic diseases including skin disorders - Subjects who can be observed and traced throughout the entire study period

Exclusion criteria

Exclusion criteria: - Subjects who are and/or have plan of pregnant or breast feeding - Subjects who have psychiatric disease and infectious skin disease - Subjects who have used an ointment containing steroids for more than 1 month - Subjects who participated in the similar test within the past 6 months - Subject s who have sensitive and hypersensitive skin - Subjects who have skin disorders on the test site such as moles, pimples, red spots, scalds (burns), hemotelangiosis, and scars - Subjects who have used cosmetics or drugs on the test site with similar efficacy with in the past 3 months - Subjects who received treatment from dermatologist or aestheticians on the test site within the past 6 months - Those who are employed in this clinical trial center - Those who are considered as a nonqualified person by judge or the inve stigator

Design outcomes

Primary

Measure	Time frame
facial wrinkles (eye area, nasolabial folds);facial lifting ;skin density;melasma and pigmentation;skin texture;pores	—

Secondary

Measure	Time frame
Efficacy self report questionnaire;Assessment of s kin adverse reaction	—

Countries

Korea, Republic of

Contacts

Public ContactLim Heejin

Human Co., Ltd. Skin Clinical Trial Center

ihj@humantest.co.kr+82-70-4680-5844

Outcome results